U.S. District Judge Dabney Friedrich all but told the federal government during a court hearing in Washington, D.C., on Tuesday she rejects its basic argument that the plain text of the 340B statute requires drug manufacturers to honor 340B purchases by covered entities regardless of whether those entities use contract pharmacy services.
Friedrich spent much of the 90-minute hearing quizzing lawyers for drug makers Novartis and United Therapeutics and the federal government about other possible grounds upon which the government might win the cases that the two companies have brought against it.
U.S. District Judge Dabney Friedrich all but told the federal government during a court hearing in Washington, D.C., on Tuesday she rejects its basic argument that the plain text of 340B statute requires drug manufacturers to honor 340B purchases by covered entities regardless of whether those entities use contract pharmacy services.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
